CA2251798C - Animal feed additives - Google Patents
Animal feed additives Download PDFInfo
- Publication number
- CA2251798C CA2251798C CA002251798A CA2251798A CA2251798C CA 2251798 C CA2251798 C CA 2251798C CA 002251798 A CA002251798 A CA 002251798A CA 2251798 A CA2251798 A CA 2251798A CA 2251798 C CA2251798 C CA 2251798C
- Authority
- CA
- Canada
- Prior art keywords
- type
- enzymes
- animal feed
- xylanolytic
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000019730 animal feed additive Nutrition 0.000 title claims abstract description 39
- 102000004190 Enzymes Human genes 0.000 claims abstract description 137
- 108090000790 Enzymes Proteins 0.000 claims abstract description 137
- 241001465754 Metazoa Species 0.000 claims abstract description 24
- 238000002360 preparation method Methods 0.000 claims description 67
- 230000000694 effects Effects 0.000 claims description 52
- 241000209140 Triticum Species 0.000 claims description 43
- 235000021307 Triticum Nutrition 0.000 claims description 43
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 claims description 35
- 239000000725 suspension Substances 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 19
- 230000000996 additive effect Effects 0.000 claims description 9
- 230000002708 enhancing effect Effects 0.000 claims description 9
- 229920001221 xylan Polymers 0.000 claims description 9
- 241000223259 Trichoderma Species 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 150000004823 xylans Chemical class 0.000 claims description 6
- 241001480714 Humicola insolens Species 0.000 claims description 5
- 241000223258 Thermomyces lanuginosus Species 0.000 claims description 5
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 claims description 4
- 108010013043 Acetylesterase Proteins 0.000 claims description 4
- 229920000189 Arabinogalactan Polymers 0.000 claims description 4
- 239000001904 Arabinogalactan Substances 0.000 claims description 4
- 102100036617 Monoacylglycerol lipase ABHD2 Human genes 0.000 claims description 4
- 108010059820 Polygalacturonase Proteins 0.000 claims description 4
- 241000499912 Trichoderma reesei Species 0.000 claims description 4
- 235000019312 arabinogalactan Nutrition 0.000 claims description 4
- 230000007423 decrease Effects 0.000 claims description 4
- 241000228215 Aspergillus aculeatus Species 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 3
- 230000000593 degrading effect Effects 0.000 claims description 3
- 108010011619 6-Phytase Proteins 0.000 claims description 2
- 101710152845 Arabinogalactan endo-beta-1,4-galactanase Proteins 0.000 claims description 2
- 102100032487 Beta-mannosidase Human genes 0.000 claims description 2
- 108010059892 Cellulase Proteins 0.000 claims description 2
- 101001096557 Dickeya dadantii (strain 3937) Rhamnogalacturonate lyase Proteins 0.000 claims description 2
- 101710147028 Endo-beta-1,4-galactanase Proteins 0.000 claims description 2
- 108090001060 Lipase Proteins 0.000 claims description 2
- 102000004882 Lipase Human genes 0.000 claims description 2
- 229920000057 Mannan Polymers 0.000 claims description 2
- 108010029182 Pectin lyase Proteins 0.000 claims description 2
- 108091005804 Peptidases Proteins 0.000 claims description 2
- 102000035195 Peptidases Human genes 0.000 claims description 2
- 239000004365 Protease Substances 0.000 claims description 2
- 241000223262 Trichoderma longibrachiatum Species 0.000 claims description 2
- 108010027199 Xylosidases Proteins 0.000 claims description 2
- -1 arabinanases Proteins 0.000 claims description 2
- 102000005936 beta-Galactosidase Human genes 0.000 claims description 2
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 2
- 108010055059 beta-Mannosidase Proteins 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims description 2
- 108010005400 cutinase Proteins 0.000 claims description 2
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 2
- 230000002366 lipolytic effect Effects 0.000 claims description 2
- 108010087558 pectate lyase Proteins 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 108020004410 pectinesterase Proteins 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 108010035322 rhamnogalacturonan acetylesterase Proteins 0.000 claims description 2
- 229940088598 enzyme Drugs 0.000 description 96
- 230000009471 action Effects 0.000 description 12
- 108010019160 Pancreatin Proteins 0.000 description 9
- 102000057297 Pepsin A Human genes 0.000 description 9
- 108090000284 Pepsin A Proteins 0.000 description 9
- 229940055695 pancreatin Drugs 0.000 description 9
- 229940111202 pepsin Drugs 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 239000000523 sample Substances 0.000 description 7
- 238000011534 incubation Methods 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 230000002195 synergetic effect Effects 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 4
- 108010001817 Endo-1,4-beta Xylanases Proteins 0.000 description 3
- 240000005979 Hordeum vulgare Species 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- 239000003674 animal food additive Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 101000666763 Aspergillus aculeatus Endo-1,4-beta-xylanase Proteins 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 101710132690 Endo-1,4-beta-xylanase A Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920001706 Glucuronoxylan Polymers 0.000 description 2
- 241000223198 Humicola Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000007238 Secale cereale Nutrition 0.000 description 2
- 244000082988 Secale cereale Species 0.000 description 2
- 101000770834 Thermomyces lanuginosus Endo-1,4-beta-xylanase Proteins 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 229920000617 arabinoxylan Polymers 0.000 description 2
- 150000004783 arabinoxylans Chemical class 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000012496 blank sample Substances 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000006047 digesta Substances 0.000 description 2
- 235000019621 digestibility Nutrition 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 1
- 241001513093 Aspergillus awamori Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 101000756530 Aspergillus niger Endo-1,4-beta-xylanase B Proteins 0.000 description 1
- 241000228232 Aspergillus tubingensis Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000228439 Bipolaris zeicola Species 0.000 description 1
- 241000228437 Cochliobolus Species 0.000 description 1
- 241000863390 Dictyoglomus Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241000187267 Microtetraspora Species 0.000 description 1
- 241000233892 Neocallimastix Species 0.000 description 1
- 241000233894 Neocallimastix patriciarum Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000252565 Pseudothermotoga thermarum Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241001148569 Rhodothermus Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000223257 Thermomyces Species 0.000 description 1
- 241000204652 Thermotoga Species 0.000 description 1
- 241000204666 Thermotoga maritima Species 0.000 description 1
- 241000204664 Thermotoga neapolitana Species 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 235000021405 artificial diet Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000019751 broiler diet Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004317 gizzard Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 230000009290 primary effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- KUIXZSYWBHSYCN-UHFFFAOYSA-L remazol brilliant blue r Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(N)=C2C(=O)C3=CC=CC=C3C(=O)C2=C1NC1=CC=CC(S(=O)(=O)CCOS([O-])(=O)=O)=C1 KUIXZSYWBHSYCN-UHFFFAOYSA-L 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000013179 statistical model Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 210000002438 upper gastrointestinal tract Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Fodder In General (AREA)
Abstract
The present invention relates to the combined use, simultaneous or sequential, of one or more xylanolytic enzymes of Type I with one or more xylanolytic enzymes of Type II in animal feed. It also relates to animal feed and animal feed additives comprising such combination of xylanolytic enzymes.
Description
ANIMAL FEED ADDITIVES
TECHNICAL FIELD
The present invention relates to the combined use in animal feed of one or more xylanolytic enzymes of Type I with one or more xylanolytic enzymes of Type II, as defined herein. It also relates to animal feed and animal feed additives comprising such combination of xylanolytic enzymes.
BACKGROUND ART
The types and amount of plant raw materials which can be used as components in animal feed will often be limited by the ability of the animals to digest them. Feed enhancing enzymes are enzymes, usually of microbial origin, that by improving feed digestibility are able to increase the efficiency of its utilization.
When added to animal feed, feed enhancing enzymes improve the in vivo break-down of plant cell wall material partly due to a reduction of the intestinal viscosity, whereby a better utilization of the plant nutrients by the animal is achieved.
In this way the growth rate andlor feed conversion ratio (i.e. the weight of ingested 2o feed relative to weight gain) of the animal becomes improved.
Xylanolytic enzymes (EC 3.2.1.8) are well known as feed enhancing enzymes. According to one theory, their primary effect is to reduce the viscosity of the feed, whereas another theory focuses on the xylanases increasing the availability of nutrients embedded in the plant cell wall. Thus WO 94/21785 2s describes xylanases derived from Aspergillus aculeatus and their use as animal feed additives, in particular in animal feed compositions containing high amounts of arabinoxylans and glucuronoxylans, e.g. feed containing cereals such as barley, wheat, rye or oats or maize.
WO 95123514 describes a process for reducing the viscosity of a plant so material and for separating plant material into desirable components, which process comprises treating the plant material with a xylanase preparation having a specific activity on water-soluble/water in-soluble pentosans. However, WO 95/23514 does
TECHNICAL FIELD
The present invention relates to the combined use in animal feed of one or more xylanolytic enzymes of Type I with one or more xylanolytic enzymes of Type II, as defined herein. It also relates to animal feed and animal feed additives comprising such combination of xylanolytic enzymes.
BACKGROUND ART
The types and amount of plant raw materials which can be used as components in animal feed will often be limited by the ability of the animals to digest them. Feed enhancing enzymes are enzymes, usually of microbial origin, that by improving feed digestibility are able to increase the efficiency of its utilization.
When added to animal feed, feed enhancing enzymes improve the in vivo break-down of plant cell wall material partly due to a reduction of the intestinal viscosity, whereby a better utilization of the plant nutrients by the animal is achieved.
In this way the growth rate andlor feed conversion ratio (i.e. the weight of ingested 2o feed relative to weight gain) of the animal becomes improved.
Xylanolytic enzymes (EC 3.2.1.8) are well known as feed enhancing enzymes. According to one theory, their primary effect is to reduce the viscosity of the feed, whereas another theory focuses on the xylanases increasing the availability of nutrients embedded in the plant cell wall. Thus WO 94/21785 2s describes xylanases derived from Aspergillus aculeatus and their use as animal feed additives, in particular in animal feed compositions containing high amounts of arabinoxylans and glucuronoxylans, e.g. feed containing cereals such as barley, wheat, rye or oats or maize.
WO 95123514 describes a process for reducing the viscosity of a plant so material and for separating plant material into desirable components, which process comprises treating the plant material with a xylanase preparation having a specific activity on water-soluble/water in-soluble pentosans. However, WO 95/23514 does
2 -not relate to mixtures of xylanases.
SUMMARY OF THE INVENTION
s According to the present invention it has now been found that xylanolytic enzymes can be distinguished by the way they degrade different substrates. Moreover it has surprisingly been found that the combined action of two different types of xylanolytic enzymes is improved as compared to the action of the two separate enzymes, i.e. a synergistic effect occurs.
Therefore, one main object of the invention is the combined use of these two types of xylanolytic enzymes in animal feed. In particular, they are used simultaneously and/or sequentially.
It is another main object of the present invention to provide an animal feed additive which increases energy uptake from animal feed. Accordingly, in one ~ s main aspect, the present invention provides an animal feed additive which comprises a mixture of one or more xylanolytic enzymes of Type I with one or more xylanolytic enzymes of Type II, Type I and Type II as defined herein.
BRIEF DESCRIPTION OF THE DRAWINGS
The present invention is further illustrated by reference to the accompanying drawing, in which:
Fig. 1 shows the action of six different xylanolytic enzymes [viz. a multicomponent Trichoderma reesei xylanase preparation (A); a monocomponent 2s Aspergillus aculeatus xylanase preparation (B); a monocomponent Humicola insolens xylanase preparation (C); a monocomponent Thermomyces lanuginosus xylanase preparation (D); a multicomponent Humicola insolens xylanase preparation (E) and a multicomponent Trichoderma xylanase preparation (F)] on the viscosity of a wheat suspension determined after the so-called pepsin phase according to 3o Example 1, presented as relative viscosity (%) versus enzyme concentration (FXU/g wheat);
SUMMARY OF THE INVENTION
s According to the present invention it has now been found that xylanolytic enzymes can be distinguished by the way they degrade different substrates. Moreover it has surprisingly been found that the combined action of two different types of xylanolytic enzymes is improved as compared to the action of the two separate enzymes, i.e. a synergistic effect occurs.
Therefore, one main object of the invention is the combined use of these two types of xylanolytic enzymes in animal feed. In particular, they are used simultaneously and/or sequentially.
It is another main object of the present invention to provide an animal feed additive which increases energy uptake from animal feed. Accordingly, in one ~ s main aspect, the present invention provides an animal feed additive which comprises a mixture of one or more xylanolytic enzymes of Type I with one or more xylanolytic enzymes of Type II, Type I and Type II as defined herein.
BRIEF DESCRIPTION OF THE DRAWINGS
The present invention is further illustrated by reference to the accompanying drawing, in which:
Fig. 1 shows the action of six different xylanolytic enzymes [viz. a multicomponent Trichoderma reesei xylanase preparation (A); a monocomponent 2s Aspergillus aculeatus xylanase preparation (B); a monocomponent Humicola insolens xylanase preparation (C); a monocomponent Thermomyces lanuginosus xylanase preparation (D); a multicomponent Humicola insolens xylanase preparation (E) and a multicomponent Trichoderma xylanase preparation (F)] on the viscosity of a wheat suspension determined after the so-called pepsin phase according to 3o Example 1, presented as relative viscosity (%) versus enzyme concentration (FXU/g wheat);
3 Fig. 2 shows the action of the same six enzymes as in fig. 1 on the viscosity of a wheat suspension, also presented as relative viscosity {%) versus enzyme concentration (FXU/g wheat), but here determined after the so-called ° pancreatin phase according to Example 1;
Fig. 3 shows the effect, determined after the pepsin phase, on the viscosity of a wheat suspension of two individual Type I and Type II xylanase preparations (viz. preparations D and A, respectively) compared to that of the mixture of these two preparations as well as a theoretically calculated additive effect;
the effect is presented as % relative viscosity; columns I the combined effect of preparations A and D; columns II theoretical additive effect of preparations A
and D;
columns ill the effect of preparation D alone; and columns IV the effect of preparation A alone; and Fig. 4 shows, as in fig. 3, the effect on the viscosity of a wheat suspension of the same two individual Type I and Type II xylanase preparations, but here as determined after the pancreatin phase.
DETAILED DISCLOSURE OF THE INVENTION
Xylanolytic Enzymes of Type I and Type II
2o According to the present invention it has now been found that xylanolytic enzymes can be distinguished by the way they degrade different substrates. Moreover it has surprisingly been found that the combined action of two different types of xylanolytic enzymes is increased as compared to the action of the two separate enzymes, i.e. a synergistic effect occurs.
2s The type of a xylanolytic enzyme may e.g. be determined by reference to its action on the viscosity of a wheat suspension. As defined herein, xylanolytic enzymes of Type I increase initial viscosity of a wheat suspension, whereas the initial viscosity of a wheat suspension is unaffected or becomes decreased by the action of a xylanolytic enzyme of Type II. In particular, the increased initial viscosity 3o referred to above refers to figs. 1 and 2 hereof, which show an initially or at low FXU-doses increased relative viscosity.
Fig. 3 shows the effect, determined after the pepsin phase, on the viscosity of a wheat suspension of two individual Type I and Type II xylanase preparations (viz. preparations D and A, respectively) compared to that of the mixture of these two preparations as well as a theoretically calculated additive effect;
the effect is presented as % relative viscosity; columns I the combined effect of preparations A and D; columns II theoretical additive effect of preparations A
and D;
columns ill the effect of preparation D alone; and columns IV the effect of preparation A alone; and Fig. 4 shows, as in fig. 3, the effect on the viscosity of a wheat suspension of the same two individual Type I and Type II xylanase preparations, but here as determined after the pancreatin phase.
DETAILED DISCLOSURE OF THE INVENTION
Xylanolytic Enzymes of Type I and Type II
2o According to the present invention it has now been found that xylanolytic enzymes can be distinguished by the way they degrade different substrates. Moreover it has surprisingly been found that the combined action of two different types of xylanolytic enzymes is increased as compared to the action of the two separate enzymes, i.e. a synergistic effect occurs.
2s The type of a xylanolytic enzyme may e.g. be determined by reference to its action on the viscosity of a wheat suspension. As defined herein, xylanolytic enzymes of Type I increase initial viscosity of a wheat suspension, whereas the initial viscosity of a wheat suspension is unaffected or becomes decreased by the action of a xylanolytic enzyme of Type II. In particular, the increased initial viscosity 3o referred to above refers to figs. 1 and 2 hereof, which show an initially or at low FXU-doses increased relative viscosity.
4 The combined action of the two different types of xylanolytic enzymes referred to above can be simultaneous, i.e. the two enzymes are active at the same time, or sequential, i.e. one type is acting first, the second type subsequently. In the sequential type of action the first type may be active or non-active, when the second s type excerts its effect, viz. a simultaneous and sequential, and a pure sequential action, respectively. In all these cases a synergistic effect is observed on the viscosity of the feed.
An assay for determining the type of xylanolytic enzyme is described in more detail in Example 1.
Animal Feed and Animal Feed Additives The present invention provides an animal feed as well as an animal feed additive, which comprises a mixture of one or more xylanolytic enzymes of Type I with one or more xylanolytic enzymes of Type li.
In the context of this invention, in particular, an animal feed means any natural or artificial diet, meal or the like or components of such meals intended or suitable for being eaten, taken in, or digested by an animal.
In the context of this invention, an animal feed additive is an enzyme preparation comprising one or more feed enhancing enzymes) and suitable carriers 2o and/or excipients. In particular, the enzyme preparation is provided in a form that is suitable for being added to animal feed. The animal feed additive of the invention may be prepared in accordance with methods known in the art and may be provided in the form of a dry preparation or a liquid preparation. The enzyme to be included in the preparation, may optionally be stabilized in accordance with methods known in the art.
The animal feed additive of the invention may be a granulated enzyme product which may readily be mixed with feed components, or more preferably, form a component of a pre-mix. The granulated enzyme product may be coated or uncoated. The particle size of the enzyme granulates preferably is compatible with 3o that of feed and pre-mix components. This provides a safe and convenient mean of incorporating enzymes into feeds.
Also, the animal feed additive of the invention may be a stabilized liquid composition, which may be an aqueous or oil-based slurry.
The animal feed additive of the invention may exert its effect either in vitro or in vivo. The effect may be exerted by pre-treating an animal feed, if desired followed by an inactivation of the enzymes. But usually the xylanases exert their effect in vivo, i.e. they act directly in the digestive system of the animal, during the digestion. The feed additive of the invention is particularly suited for addition to animal feed compositions containing high amounts of arabinoxylans and glucuronoxylans, e.g. feed containing cereals such as wheat, barley, rye, oats, or maize.
In a preferred embodiment an animal feed additive is provided in which the ratio of xylanolytic enzymes of Type I to xylanolytic enzymes of Type 11 is in the range of from about 119 to about 9/1, determined in terms of xylanolytic activity, i.e.
10-90% of the total amount of xylanolytic activity, e.g. determined in terms of FXU, is ~ 5 ascribable to a xylanolytic enzyme of Type I.
In another preferred embodiment an animal feed additive is provided in which the ratio of xylanofytic enzymes of Type I to xylanolytic enzymes of Type II is in the range of from about 2/8 to about 8/2, determined in terms of xylanolytic activity, i.e. 20-80% of the total amount of xylanolytic activity, e.g.
determined in 2o terms of FXU, is ascribable to a xylanolytic enzyme of Type I.
In a third preferred embodiment an animal feed additive is provided in which the ratio of xylanolytic enzymes of Type I to xylanolytic enzymes of Type II is in the range of from about 317 to about 7/3, determined in terms of xylanolytic activity, i.e. 30-70% of the total amount of xylanolytic activity, e.g.
determined in 25 terms of FXU, is ascribable to a xylanolytic enzyme of Type I.
In a fourth preferred embodiment an animal feed additive is provided in which the ratio of xylanoiytic enzymes of Type I to xylanolytic enzymes of Type II is in the range of from about 4/6 to about 6/4, determined in terms of xylanolytic activity, i.e. 40-60% of the total amount of xylanoiytic activity, e.g.
determined in 3o terms of FXU, is ascribable to a xylanolytic enzyme of Type I.
In a fifth preferred embodiment an animal feed additive is provided in which the ratio of xylanolytic enzymes of Type I to xylanolytic enzymes of Type II is about 515, determined in terms of xylanolytic activity, i.e. xylanolytic enzymes of Type I and Type II is present in approximately equal activities, e.g. determined in terms of FXU.
In a sixth preferred embodiment an animal feed additive is provided in s which the ratio of xylanofytic enzymes of Type I to xylanolytic enzymes of Type II is in the range of from about 1/20 to about 20/1, determined in terms of xylanolytic activity, i.e. 5-95% of the total amount of xylanolytic activity, e.g.
determined in terms of FXU, is ascribable to a xylanolytic enzyme of Type I. The particular embodiment of 1/20 of type Illtype I has turned up to be very satisfactory.
Other preferred ratios are 125:1, 100:1, 75:1, 50:1 and 25:1 (type I : type I I or vice versa).
Monocomponent Preparations In a preferred embodiment, the present invention provides an animal ~ 5 feed additive, in which one or more of the xylanolytic enzymes are provided in the form of a monocomponent preparation. In the context of this invention, a monocomponent preparation is an enzyme preparation, in which preparation essentially all of the xylanolytic activity (i.e. the xylanolytic activity detectable) is owing to a single xylanase component. The monocomponent preparation may 2o preferably be obtained by way of recombinant DNA technology.
In a more specific embodiment all xylanolytic enzymes are provided in the form of monocomponent preparations.
Feed Enhancing Enzymes 2s In a further preferred embodiment, the feed additive of the invention comprises additional feed enhancing enzymes.
In the context of this invention feed enhancing enzymes comprise but are not limited to other xyianases, a-galactosidases, ~i-galactosidases, in particular lactases, phytases, ~3-glucanases, in particular endo-(i-1,4-glucanases and endo-~3-30 1,3(4)-glucanases, xylosidases, galactanases, in particular arabinogalactan endo-1,4-~-galactosidases and arabinogalactan endo-1,3-~-galactosidases, endoglucanases, in particular endo-1,2-(3-glucanase, endo-1,3-a-glucanase, and endo-1,3-~-giucanase, pectin degrading enzymes, in particular pectinases, pectinesterases, pectin lyases, polygalacturonases, arabinanases, rhamnogalacturonases, rhamnogalacturonan acetyl esterases, rhamnogalacturonan-a-rhamnosidase, pectate lyases, and a-galacturonisidases, mannanases, ~3-rnannosidases, mannan acetyl esterases, xylan acetyl esterases, proteases and lipolytic enzymes such as lipases and cutinases.
Microbial Sources The xylanolytic enzymes of Type I and Type II according to the invention may originate from any source of xylanolytic enzymes. Preferably the xylanolytic enzymes are originally derived from microbial sources, and may in particular be of fungal origin, of bacterial origin, or derived from a yeast strain. In case of recombinant xylanoiytic enzymes, any host cell can be employed for their production such as fungi, bacteria, yeast, transgenic plants or animal cell lines.
Preferred xylanolytic enzymes of fungal origin are xylanases originally derived from a strain of Aspergillus, in particular Aspergillus aculeatus, Aspergillus awamori, Aspergillus niger, Aspergillus tubigensis, a strain of Cochliobolus, in particular Cochliobolus carbonum, a strain of Disporotrichum, in particular Disporotrichum dimorphosporum, a strain of Humicola, in particular Humicola 2o insolens, a strain of Neocallimastix, in particular Neocallimastix patriciarum, a strain of Thermomyces, in particular Thermomyces lanuginosus (syn. Humicola lanuginosa), or a strain of Trichoderma, in particular Trichoderma Iongibrachiatum and Trichoderma reesei.
Preferred xylanolytic enzymes of bacterial origin are xylanases derived from a strain of Bacillus, in particular Bacillus pumilus, Bacillus stearothermophilus, a strain of Dictyoglomus, in particular Dicfyoglomus thermophilum, a strain of Microtetraspora, in particular Microtefraspora flexuosa, a strain of Streptomyces, a strain of Thermotoga, in particular a strain of Thermotoga neapolitana, Thermotoga maritima and Thermotoga thermarum, or a strain of Rhodothermus.
3o In a preferred embodiment the animal feed additive of the invention comprises a xylanolytic enzyme of Type I derived from a strain of Thermomyces lanuginosus which is provided in the form of a monocomponent preparation.
In another preferred embodiment the animal feed additive of the invention comprises a xylanolytic enzyme of Type II derived from a strain of Trichoderma which is provided in the form of a monocomponent preparation.
s Xylanolytic Activity The xylanolytic activity can be expressed in FXU-units, determined at pH 6.0 with remazol-xylan (4-O-methyl-D-glucurono-D-xylan dyed with Remazol Brilliant Blue R, Fluka) as substrate.
A xylanase sample is incubated with the remazol-xylan substrate. The background of non-degraded dyed substrate is precipitated by ethanol as a stop reagent. The remaining blue color in the supernatant (as determined spectrophotometricaily at 585 nm) is proportional to the xylanase activity, and the xylanase units are then determined relatively to an enzyme standard at standard reaction conditions, i.e. at 50.0°C and 30 minutes reaction time in a 0.1 M phosphate 15 buffer pH 6Ø
EXAMPLES
The invention is further illustrated with reference to the following 2o examples which are not intended to be in any way limiting to the scope of the invention as claimed.
Example 1 Determination of Type of Xylanolytic Enzyme 25 This example demonstrates how xylanolytic enzymes can be distinguished by the way they affect the viscosity of a wheat suspension, and how they can be classified xylanolytic enzymes of Type I and Type II, respectively.
Xylanolytic enzymes of Type I increase the initial viscosity of a wheat suspension, whereas the initial viscosity of a wheat suspension is unaffected or becomes so decreased by the action of a xylanolytic enzyme of Type II.
Foregut digesta viscosity has been identified as a major nutritional constraint affecting digestibility of wheat and barley based broiler diets. A
close correlation between the reduction of digesta viscosity results and improvements in chicken feed conversion efficiency have been found.
In this example six different xylanolytic enzymes are examined with a respect to their activity on initial viscosity of a wheat suspension:
s A) A multicomponent Trichoderma reesei {previously identified as Trichoderma longibrachiatum) xylanase preparation (enzyme complex, NovozymTM
431, available from Novo Nordisk A/S, Denmark);
B) A monocomponent Aspergillus aculeatus xylanase preparation obtained according to Example 3 of WO 94/21785;
C) A monocomponent Humicola insolens xylanase preparation obtained according to Example 1 of WO 92/17573;
D) A monocomponent Thermomyces lanuginosus xylanase preparation obtained according to Examples 1-3 of WO 96/23062;
E) A multicomponent Humicola insolens xylanase preparation (enzyme complex, Bio-Feed Plus CT, available from Novo Nordisk A/S, Denmark); and F) A multicomponent Trichoderma xylanase preparation (enzyme complex, AvizymeTM 1300, available from Finnfeeds, Finland).
The determination is carried out under conditions that mimic the conditions of the gastro-intestinal tract of poultries. Therefore two determinations are 2o made, one after incubation for 45 minutes in presence of pepsin (the pepsin phase, which mimics the conditions of the gizzard), and one after additional 120 minutes in presence of pancreatin (the pancreatin phase, which mimics the conditions of the small intestine).
Therefore two samples and two reference solutions (blank sample, 2s control) are prepared, each containing 8.00 g of ground wheat in 12 ml of a solution of 1.042 g of pepsin in 250 ml of 0.1 N HCI. After stirring for 2 minutes, a solution of the xylanase sample in question is added to the two samples, and this point is accorded the time zero (t = 0). The controls are added the same volume of a 1 M
NaHC03.
3o After 45 minutes (t = 45) of incubation under stirring at 40°C, 4 ml of a 1 M NaHC03 solution is a added to one of the samples, and this sample is now being cooled to 0°C. This sample represents the pepsin phase. Also at t = 45, 4 ml 1 M
NaHC03 is added to one of the controls.
At the same time (t = 45) 4 ml of the supernatant of a solution containing 200 mg pancreatin in 50 ml of 1 M NaHC03 solution is added to the second sample. After additional 120 minutes (t = 165) of incubation under stirring at
An assay for determining the type of xylanolytic enzyme is described in more detail in Example 1.
Animal Feed and Animal Feed Additives The present invention provides an animal feed as well as an animal feed additive, which comprises a mixture of one or more xylanolytic enzymes of Type I with one or more xylanolytic enzymes of Type li.
In the context of this invention, in particular, an animal feed means any natural or artificial diet, meal or the like or components of such meals intended or suitable for being eaten, taken in, or digested by an animal.
In the context of this invention, an animal feed additive is an enzyme preparation comprising one or more feed enhancing enzymes) and suitable carriers 2o and/or excipients. In particular, the enzyme preparation is provided in a form that is suitable for being added to animal feed. The animal feed additive of the invention may be prepared in accordance with methods known in the art and may be provided in the form of a dry preparation or a liquid preparation. The enzyme to be included in the preparation, may optionally be stabilized in accordance with methods known in the art.
The animal feed additive of the invention may be a granulated enzyme product which may readily be mixed with feed components, or more preferably, form a component of a pre-mix. The granulated enzyme product may be coated or uncoated. The particle size of the enzyme granulates preferably is compatible with 3o that of feed and pre-mix components. This provides a safe and convenient mean of incorporating enzymes into feeds.
Also, the animal feed additive of the invention may be a stabilized liquid composition, which may be an aqueous or oil-based slurry.
The animal feed additive of the invention may exert its effect either in vitro or in vivo. The effect may be exerted by pre-treating an animal feed, if desired followed by an inactivation of the enzymes. But usually the xylanases exert their effect in vivo, i.e. they act directly in the digestive system of the animal, during the digestion. The feed additive of the invention is particularly suited for addition to animal feed compositions containing high amounts of arabinoxylans and glucuronoxylans, e.g. feed containing cereals such as wheat, barley, rye, oats, or maize.
In a preferred embodiment an animal feed additive is provided in which the ratio of xylanolytic enzymes of Type I to xylanolytic enzymes of Type 11 is in the range of from about 119 to about 9/1, determined in terms of xylanolytic activity, i.e.
10-90% of the total amount of xylanolytic activity, e.g. determined in terms of FXU, is ~ 5 ascribable to a xylanolytic enzyme of Type I.
In another preferred embodiment an animal feed additive is provided in which the ratio of xylanofytic enzymes of Type I to xylanolytic enzymes of Type II is in the range of from about 2/8 to about 8/2, determined in terms of xylanolytic activity, i.e. 20-80% of the total amount of xylanolytic activity, e.g.
determined in 2o terms of FXU, is ascribable to a xylanolytic enzyme of Type I.
In a third preferred embodiment an animal feed additive is provided in which the ratio of xylanolytic enzymes of Type I to xylanolytic enzymes of Type II is in the range of from about 317 to about 7/3, determined in terms of xylanolytic activity, i.e. 30-70% of the total amount of xylanolytic activity, e.g.
determined in 25 terms of FXU, is ascribable to a xylanolytic enzyme of Type I.
In a fourth preferred embodiment an animal feed additive is provided in which the ratio of xylanoiytic enzymes of Type I to xylanolytic enzymes of Type II is in the range of from about 4/6 to about 6/4, determined in terms of xylanolytic activity, i.e. 40-60% of the total amount of xylanoiytic activity, e.g.
determined in 3o terms of FXU, is ascribable to a xylanolytic enzyme of Type I.
In a fifth preferred embodiment an animal feed additive is provided in which the ratio of xylanolytic enzymes of Type I to xylanolytic enzymes of Type II is about 515, determined in terms of xylanolytic activity, i.e. xylanolytic enzymes of Type I and Type II is present in approximately equal activities, e.g. determined in terms of FXU.
In a sixth preferred embodiment an animal feed additive is provided in s which the ratio of xylanofytic enzymes of Type I to xylanolytic enzymes of Type II is in the range of from about 1/20 to about 20/1, determined in terms of xylanolytic activity, i.e. 5-95% of the total amount of xylanolytic activity, e.g.
determined in terms of FXU, is ascribable to a xylanolytic enzyme of Type I. The particular embodiment of 1/20 of type Illtype I has turned up to be very satisfactory.
Other preferred ratios are 125:1, 100:1, 75:1, 50:1 and 25:1 (type I : type I I or vice versa).
Monocomponent Preparations In a preferred embodiment, the present invention provides an animal ~ 5 feed additive, in which one or more of the xylanolytic enzymes are provided in the form of a monocomponent preparation. In the context of this invention, a monocomponent preparation is an enzyme preparation, in which preparation essentially all of the xylanolytic activity (i.e. the xylanolytic activity detectable) is owing to a single xylanase component. The monocomponent preparation may 2o preferably be obtained by way of recombinant DNA technology.
In a more specific embodiment all xylanolytic enzymes are provided in the form of monocomponent preparations.
Feed Enhancing Enzymes 2s In a further preferred embodiment, the feed additive of the invention comprises additional feed enhancing enzymes.
In the context of this invention feed enhancing enzymes comprise but are not limited to other xyianases, a-galactosidases, ~i-galactosidases, in particular lactases, phytases, ~3-glucanases, in particular endo-(i-1,4-glucanases and endo-~3-30 1,3(4)-glucanases, xylosidases, galactanases, in particular arabinogalactan endo-1,4-~-galactosidases and arabinogalactan endo-1,3-~-galactosidases, endoglucanases, in particular endo-1,2-(3-glucanase, endo-1,3-a-glucanase, and endo-1,3-~-giucanase, pectin degrading enzymes, in particular pectinases, pectinesterases, pectin lyases, polygalacturonases, arabinanases, rhamnogalacturonases, rhamnogalacturonan acetyl esterases, rhamnogalacturonan-a-rhamnosidase, pectate lyases, and a-galacturonisidases, mannanases, ~3-rnannosidases, mannan acetyl esterases, xylan acetyl esterases, proteases and lipolytic enzymes such as lipases and cutinases.
Microbial Sources The xylanolytic enzymes of Type I and Type II according to the invention may originate from any source of xylanolytic enzymes. Preferably the xylanolytic enzymes are originally derived from microbial sources, and may in particular be of fungal origin, of bacterial origin, or derived from a yeast strain. In case of recombinant xylanoiytic enzymes, any host cell can be employed for their production such as fungi, bacteria, yeast, transgenic plants or animal cell lines.
Preferred xylanolytic enzymes of fungal origin are xylanases originally derived from a strain of Aspergillus, in particular Aspergillus aculeatus, Aspergillus awamori, Aspergillus niger, Aspergillus tubigensis, a strain of Cochliobolus, in particular Cochliobolus carbonum, a strain of Disporotrichum, in particular Disporotrichum dimorphosporum, a strain of Humicola, in particular Humicola 2o insolens, a strain of Neocallimastix, in particular Neocallimastix patriciarum, a strain of Thermomyces, in particular Thermomyces lanuginosus (syn. Humicola lanuginosa), or a strain of Trichoderma, in particular Trichoderma Iongibrachiatum and Trichoderma reesei.
Preferred xylanolytic enzymes of bacterial origin are xylanases derived from a strain of Bacillus, in particular Bacillus pumilus, Bacillus stearothermophilus, a strain of Dictyoglomus, in particular Dicfyoglomus thermophilum, a strain of Microtetraspora, in particular Microtefraspora flexuosa, a strain of Streptomyces, a strain of Thermotoga, in particular a strain of Thermotoga neapolitana, Thermotoga maritima and Thermotoga thermarum, or a strain of Rhodothermus.
3o In a preferred embodiment the animal feed additive of the invention comprises a xylanolytic enzyme of Type I derived from a strain of Thermomyces lanuginosus which is provided in the form of a monocomponent preparation.
In another preferred embodiment the animal feed additive of the invention comprises a xylanolytic enzyme of Type II derived from a strain of Trichoderma which is provided in the form of a monocomponent preparation.
s Xylanolytic Activity The xylanolytic activity can be expressed in FXU-units, determined at pH 6.0 with remazol-xylan (4-O-methyl-D-glucurono-D-xylan dyed with Remazol Brilliant Blue R, Fluka) as substrate.
A xylanase sample is incubated with the remazol-xylan substrate. The background of non-degraded dyed substrate is precipitated by ethanol as a stop reagent. The remaining blue color in the supernatant (as determined spectrophotometricaily at 585 nm) is proportional to the xylanase activity, and the xylanase units are then determined relatively to an enzyme standard at standard reaction conditions, i.e. at 50.0°C and 30 minutes reaction time in a 0.1 M phosphate 15 buffer pH 6Ø
EXAMPLES
The invention is further illustrated with reference to the following 2o examples which are not intended to be in any way limiting to the scope of the invention as claimed.
Example 1 Determination of Type of Xylanolytic Enzyme 25 This example demonstrates how xylanolytic enzymes can be distinguished by the way they affect the viscosity of a wheat suspension, and how they can be classified xylanolytic enzymes of Type I and Type II, respectively.
Xylanolytic enzymes of Type I increase the initial viscosity of a wheat suspension, whereas the initial viscosity of a wheat suspension is unaffected or becomes so decreased by the action of a xylanolytic enzyme of Type II.
Foregut digesta viscosity has been identified as a major nutritional constraint affecting digestibility of wheat and barley based broiler diets. A
close correlation between the reduction of digesta viscosity results and improvements in chicken feed conversion efficiency have been found.
In this example six different xylanolytic enzymes are examined with a respect to their activity on initial viscosity of a wheat suspension:
s A) A multicomponent Trichoderma reesei {previously identified as Trichoderma longibrachiatum) xylanase preparation (enzyme complex, NovozymTM
431, available from Novo Nordisk A/S, Denmark);
B) A monocomponent Aspergillus aculeatus xylanase preparation obtained according to Example 3 of WO 94/21785;
C) A monocomponent Humicola insolens xylanase preparation obtained according to Example 1 of WO 92/17573;
D) A monocomponent Thermomyces lanuginosus xylanase preparation obtained according to Examples 1-3 of WO 96/23062;
E) A multicomponent Humicola insolens xylanase preparation (enzyme complex, Bio-Feed Plus CT, available from Novo Nordisk A/S, Denmark); and F) A multicomponent Trichoderma xylanase preparation (enzyme complex, AvizymeTM 1300, available from Finnfeeds, Finland).
The determination is carried out under conditions that mimic the conditions of the gastro-intestinal tract of poultries. Therefore two determinations are 2o made, one after incubation for 45 minutes in presence of pepsin (the pepsin phase, which mimics the conditions of the gizzard), and one after additional 120 minutes in presence of pancreatin (the pancreatin phase, which mimics the conditions of the small intestine).
Therefore two samples and two reference solutions (blank sample, 2s control) are prepared, each containing 8.00 g of ground wheat in 12 ml of a solution of 1.042 g of pepsin in 250 ml of 0.1 N HCI. After stirring for 2 minutes, a solution of the xylanase sample in question is added to the two samples, and this point is accorded the time zero (t = 0). The controls are added the same volume of a 1 M
NaHC03.
3o After 45 minutes (t = 45) of incubation under stirring at 40°C, 4 ml of a 1 M NaHC03 solution is a added to one of the samples, and this sample is now being cooled to 0°C. This sample represents the pepsin phase. Also at t = 45, 4 ml 1 M
NaHC03 is added to one of the controls.
At the same time (t = 45) 4 ml of the supernatant of a solution containing 200 mg pancreatin in 50 ml of 1 M NaHC03 solution is added to the second sample. After additional 120 minutes (t = 165) of incubation under stirring at
5 40°C the sample is cooled to 0°C. This sample represents the pancreatin phase.
Also at t = 165, 4 ml 1 M NaHC03 is added to the the second control.
After centrifugation, the supernatants of the two samples are subjected to viscosity determination on a Brookfield DV-III viscosimeter at 40°C, using spindle no. 18. The viscosity is determined relative to the viscosity of the blank sample.
The results of these determinations are presented as dose/response shown in the appended Figs. 1-2. From these figures it is noticed that the xylanolytic enzymes designated above as C, D and E represent xylanolytic enzymes of Type I
that increase the initial viscosity of the wheat suspension, and the xylanolytic enzymes designated above as A, B and F represent xylanolytic enzymes of Type II
that decrease the initial viscosity of the wheat suspension.
Example 2 Effect of Mixtures of Xylanolytic Enzymes of Type 1 and Type II
This example demonstrates the effect of mixtures of xylanolytic 2o enzymes of Type I and Type If on viscosity reduction of a wheat suspension.
Using the procedure described in example 1, above, combinations of the Type I enzymes C, D and E with the Type II xylanases A and B was examined.
The activity of the Type I xylanases was varied as shown in Table 1 (as in example 1 ), while the activity of the Type II xylanases was kept constant at the dose that gave 30 % (preparations A and B) or 60 % (preparation B) viscosity reduction after the pancreatin phase; i.e. for preparation B an activity of 0.01 FXU/g wheat, which resulted in a relative viscosity of 0.7, and an activity of 0.12 FXUIg, which resulted in a relative viscosity of 0.4; and for preparation A an activity of 0.20 FXU/g wheat, which resulted in a relative viscosity of approximately 0.7 (fig. 2).
3o Table 1 shows the relative viscosity of the in vitro test system after addition of different xylanase combinations and also the single Type I
enzymes. The viscosity is relative to the viscosity of a parallel incubation without added enzyme.
Using only a xylanase of type I, rather high doses have to be applied with a view to reducing the viscosity. However, when admixing with a xylanase of type II, a reduced viscosity results even in those cases in which the overall concentration of xylanase I + xylanase II is smaller than that concentration of s xylanase I alone, which had to be applied for observing any effect on the viscosity.
When mixing for instance 0.12 FXU of xylanase B with 0.25 FXU of xylanase C
(i.e.
overall activity 0.37 FXU) a viscosity reduction of approximately 50% is obtained in the pepsin phase - as compared with a much smaller viscosity reduction of 11 when as much as 1.2 FXU of xylanase C is used, without admixed type II
xylanase.
Usually the enzyme costs are set on an activity basis, and accordingly, when using a mixture of the type I and the type II enzymes, the enzyme costs can be reduced.
~ ~ O ~ M
O V
M O O
~
In~ INC
~7 (0 C
X O r r ~ M ~ M
N N
N O M 00 M 00 ~ 00 m - I~ 00Lt7 00l!7 COd' O
r ~ ~
~
Q r ~ ~ h.lf7 C
>. N OpDd0' t~CD ~ CO ~ N
O r r ~ I~ O I~ ~ CD
N
r 000CND ~ ~ M N ~
N
O t- O N N O f~lf~
r r 00 InM f~1l~
C
O
U r2 v aoo~
Q r ~ r m m m in g N
a c o D
d t w-O
c C c ~tll ~ c ~ c .~ c .~ c .N
.fnL .fnL .fnL
V Iw ..cN C ~ t0 N f0 ~ N
a a o.a a a.
> ~
CJlX CO m Q
H r N_ o ~ Z X o + co +
Moreover, the effect on viscosity of a wheat suspension of two individual Type I and Type II xylanase preparations (preparations D and A, respectively} has been compared to that of the mixture of these two preparation as well as a theoretically calculated additive effect. For preparation D three activity s levels were chosen, and for preparation A one activity level (that which resulted in a 30% viscosity reduction, i.e. a relative viscosity of 0.7) was chosen. The results of these experiments are presented in Figs. 3 and 4.
Fig. 3 shows the effect after the pepsin phase (after incubation for 45 minutes, cf. Example 1 ), and Fig. 4 shows the effect after the pancreatin phase (after incubation for 165 minutes, cf. Example 1 ). In these figures, the effect is presented as % relative viscosity.
The first columns (I) of each cluster represent the actual relative viscosity determined using a mixture of preparations D and A. Thus, in the first cluster of Figs. 3 and 4, columns (I), a mixture of 0.22 FXUIg wheat of preparation D
and 0.2 FXUIg wheat of preparation A was used, in the second cluster, a mixture of 0.56 FXUIg wheat of preparation D and 0.2 FXU/g wheat of preparation A was used, and in the third cluster, a mixture of 1.12 FXUIg wheat of preparation D and 0.2 FXU/g wheat of preparation A was used.
The second columns (II) of each cluster of each of fig. 3 and fig. 4 2o represent the theoretical viscosity of the mixture, calculated using a multiplicative statistical model. Thus, referring for example to fig. 3, column (II) of the first cluster represents the theoretically additive effect of using 0.22 FXUIg wheat of preparation D and 0.2 FXU/g wheat of preparation A, column {II) of the second cluster represents the theoretically additive effect of using 0.56 FXU/g wheat of preparation 25 D and 0.2 FXU/g wheat of preparation A, and column (II) of the third cluster represents the theoretically additive effect of using 1.12 FXUIg wheat of preparation D and 0.2 FXUIg wheat of preparation A.
The third and fourth columns (III and IV) of each cluster represent the actual relative viscosity determined using each of preparations D and A atone, 3o respectively. Thus, e.g. in the first cluster of Fig. 3, columns III and IV
represent the effect of using 0.42 FXUIg wheat of preparation D and 0.42 FXUIg wheat of preparation A, respectively.
It is apparent from these figures, that the actual viscosity determined using a mixture of preparations A and D is lower than the calculated additive value, and this is owing to a synergy between the enzymes.
It is presently contemplated that xylanases of Type I, such as preparation D, are acting preferably or initially (at low doses) on insoluble xylans (constituting approximately 80-90% of the total amount of xylans), thus liberating pentosans which are soluble, and therefore the viscosity is increased. These pentosans, however, are preferred substrates for the Type II xylanases, such as preparation A, so when acting in combination xylanases I and II degrade more xylans and the viscosity is adequately reduced. Still further, also other nutrients, which were originally embedded by the xylans, are made nutritionally available.
In general the synergistic effect is most pronounced when the total activity is low. This is probably because at higher activities of Type I
xylanases, they will also start degrading the soluble pentosans, thus reducing the synergistic effect.
~5 In addition, statistical analysis showed that the synergistic effect is highest during the pepsin phase, probably because the viscosity reduction here is smaller than in the pancreatin phase, thus leaving more room for improvement.
Also at t = 165, 4 ml 1 M NaHC03 is added to the the second control.
After centrifugation, the supernatants of the two samples are subjected to viscosity determination on a Brookfield DV-III viscosimeter at 40°C, using spindle no. 18. The viscosity is determined relative to the viscosity of the blank sample.
The results of these determinations are presented as dose/response shown in the appended Figs. 1-2. From these figures it is noticed that the xylanolytic enzymes designated above as C, D and E represent xylanolytic enzymes of Type I
that increase the initial viscosity of the wheat suspension, and the xylanolytic enzymes designated above as A, B and F represent xylanolytic enzymes of Type II
that decrease the initial viscosity of the wheat suspension.
Example 2 Effect of Mixtures of Xylanolytic Enzymes of Type 1 and Type II
This example demonstrates the effect of mixtures of xylanolytic 2o enzymes of Type I and Type If on viscosity reduction of a wheat suspension.
Using the procedure described in example 1, above, combinations of the Type I enzymes C, D and E with the Type II xylanases A and B was examined.
The activity of the Type I xylanases was varied as shown in Table 1 (as in example 1 ), while the activity of the Type II xylanases was kept constant at the dose that gave 30 % (preparations A and B) or 60 % (preparation B) viscosity reduction after the pancreatin phase; i.e. for preparation B an activity of 0.01 FXU/g wheat, which resulted in a relative viscosity of 0.7, and an activity of 0.12 FXUIg, which resulted in a relative viscosity of 0.4; and for preparation A an activity of 0.20 FXU/g wheat, which resulted in a relative viscosity of approximately 0.7 (fig. 2).
3o Table 1 shows the relative viscosity of the in vitro test system after addition of different xylanase combinations and also the single Type I
enzymes. The viscosity is relative to the viscosity of a parallel incubation without added enzyme.
Using only a xylanase of type I, rather high doses have to be applied with a view to reducing the viscosity. However, when admixing with a xylanase of type II, a reduced viscosity results even in those cases in which the overall concentration of xylanase I + xylanase II is smaller than that concentration of s xylanase I alone, which had to be applied for observing any effect on the viscosity.
When mixing for instance 0.12 FXU of xylanase B with 0.25 FXU of xylanase C
(i.e.
overall activity 0.37 FXU) a viscosity reduction of approximately 50% is obtained in the pepsin phase - as compared with a much smaller viscosity reduction of 11 when as much as 1.2 FXU of xylanase C is used, without admixed type II
xylanase.
Usually the enzyme costs are set on an activity basis, and accordingly, when using a mixture of the type I and the type II enzymes, the enzyme costs can be reduced.
~ ~ O ~ M
O V
M O O
~
In~ INC
~7 (0 C
X O r r ~ M ~ M
N N
N O M 00 M 00 ~ 00 m - I~ 00Lt7 00l!7 COd' O
r ~ ~
~
Q r ~ ~ h.lf7 C
>. N OpDd0' t~CD ~ CO ~ N
O r r ~ I~ O I~ ~ CD
N
r 000CND ~ ~ M N ~
N
O t- O N N O f~lf~
r r 00 InM f~1l~
C
O
U r2 v aoo~
Q r ~ r m m m in g N
a c o D
d t w-O
c C c ~tll ~ c ~ c .~ c .~ c .N
.fnL .fnL .fnL
V Iw ..cN C ~ t0 N f0 ~ N
a a o.a a a.
> ~
CJlX CO m Q
H r N_ o ~ Z X o + co +
Moreover, the effect on viscosity of a wheat suspension of two individual Type I and Type II xylanase preparations (preparations D and A, respectively} has been compared to that of the mixture of these two preparation as well as a theoretically calculated additive effect. For preparation D three activity s levels were chosen, and for preparation A one activity level (that which resulted in a 30% viscosity reduction, i.e. a relative viscosity of 0.7) was chosen. The results of these experiments are presented in Figs. 3 and 4.
Fig. 3 shows the effect after the pepsin phase (after incubation for 45 minutes, cf. Example 1 ), and Fig. 4 shows the effect after the pancreatin phase (after incubation for 165 minutes, cf. Example 1 ). In these figures, the effect is presented as % relative viscosity.
The first columns (I) of each cluster represent the actual relative viscosity determined using a mixture of preparations D and A. Thus, in the first cluster of Figs. 3 and 4, columns (I), a mixture of 0.22 FXUIg wheat of preparation D
and 0.2 FXUIg wheat of preparation A was used, in the second cluster, a mixture of 0.56 FXUIg wheat of preparation D and 0.2 FXU/g wheat of preparation A was used, and in the third cluster, a mixture of 1.12 FXUIg wheat of preparation D and 0.2 FXU/g wheat of preparation A was used.
The second columns (II) of each cluster of each of fig. 3 and fig. 4 2o represent the theoretical viscosity of the mixture, calculated using a multiplicative statistical model. Thus, referring for example to fig. 3, column (II) of the first cluster represents the theoretically additive effect of using 0.22 FXUIg wheat of preparation D and 0.2 FXU/g wheat of preparation A, column {II) of the second cluster represents the theoretically additive effect of using 0.56 FXU/g wheat of preparation 25 D and 0.2 FXU/g wheat of preparation A, and column (II) of the third cluster represents the theoretically additive effect of using 1.12 FXUIg wheat of preparation D and 0.2 FXUIg wheat of preparation A.
The third and fourth columns (III and IV) of each cluster represent the actual relative viscosity determined using each of preparations D and A atone, 3o respectively. Thus, e.g. in the first cluster of Fig. 3, columns III and IV
represent the effect of using 0.42 FXUIg wheat of preparation D and 0.42 FXUIg wheat of preparation A, respectively.
It is apparent from these figures, that the actual viscosity determined using a mixture of preparations A and D is lower than the calculated additive value, and this is owing to a synergy between the enzymes.
It is presently contemplated that xylanases of Type I, such as preparation D, are acting preferably or initially (at low doses) on insoluble xylans (constituting approximately 80-90% of the total amount of xylans), thus liberating pentosans which are soluble, and therefore the viscosity is increased. These pentosans, however, are preferred substrates for the Type II xylanases, such as preparation A, so when acting in combination xylanases I and II degrade more xylans and the viscosity is adequately reduced. Still further, also other nutrients, which were originally embedded by the xylans, are made nutritionally available.
In general the synergistic effect is most pronounced when the total activity is low. This is probably because at higher activities of Type I
xylanases, they will also start degrading the soluble pentosans, thus reducing the synergistic effect.
~5 In addition, statistical analysis showed that the synergistic effect is highest during the pepsin phase, probably because the viscosity reduction here is smaller than in the pancreatin phase, thus leaving more room for improvement.
Claims (20)
1. The combined use, simultaneous and/or sequential, in animal feed of one or more xylanolytic enzymes that increases the initial viscosity of a wheat suspension (Type I
enzyme) with one or more xylanolytic enzymes that decreases or leaves unaffected the initial viscosity of a wheat suspension (Type II enzyme).
enzyme) with one or more xylanolytic enzymes that decreases or leaves unaffected the initial viscosity of a wheat suspension (Type II enzyme).
2. An animal feed comprising a mixture of one or more xylanolytic enzymes that increases the initial viscosity of a wheat suspension (Type I enzyme) with one or more xylanolytic enzymes that decreases or leaves unaffected the initial viscosity of a wheat suspension (Type II enzyme), in which the ratio of Type I to Type II enzymes is in the range of from about 1/9 to about 9/1, determined in terms of xylanolytic activity.
3. An animal feed additive, which additive comprises a mixture of one or more xylanolytic enzymes that increases the initial viscosity of a wheat suspension (Type I
enzyme) with one or more xylanolytic enzymes that decreases or leaves unaffected the initial viscosity of a wheat suspension (Type II enzyme), in which the ratio of Type I to Type II enzymes is in the range of from about 1/9 to about 9/1.
enzyme) with one or more xylanolytic enzymes that decreases or leaves unaffected the initial viscosity of a wheat suspension (Type II enzyme), in which the ratio of Type I to Type II enzymes is in the range of from about 1/9 to about 9/1.
4. The animal feed additive according to claim 3, in which the ratio of Type I
to Type II enzymes is in the range of from about 2/8 to about 8/2, determined in terms of xylanolytic activity.
to Type II enzymes is in the range of from about 2/8 to about 8/2, determined in terms of xylanolytic activity.
5. The animal feed additive according to claim 3, in which the ratio of Type I
to Type II enzymes is in the range of from about 3/7 to about 7/3, determined in terms of xylanolytic activity.
to Type II enzymes is in the range of from about 3/7 to about 7/3, determined in terms of xylanolytic activity.
6. The animal feed additive according to claim 3, in which the ratio of Type I
to Type II enzymes is in the range of from about 4/6 to about 6/4, determined in terms of xylanolytic activity.
to Type II enzymes is in the range of from about 4/6 to about 6/4, determined in terms of xylanolytic activity.
7. The animal feed additive according to claim 3, in which the ratio of Type I
to Type II enzymes is about 5/5, determined in terms of xylanolytic activity.
to Type II enzymes is about 5/5, determined in terms of xylanolytic activity.
8. The animal feed additive according to any of claims 3-7, in which at least one xylanolytic enzyme is a Type I enzyme derived from a strain of Humicola insolens.
9. The animal feed additive according to any of claims 3-7, in which at least one xylanolytic enzyme is a Type I enzyme derived from a strain of Thermomyces lanuginosus.
10. The animal feed additive according to any of claims 3-9, in which at least one xylanolytic enzyme is a Type II enzyme derived from a strain of Aspergillus aculeatus.
11. The animal feed additive according to any of claims 3-9, in which at least one xylanolytic enzyme is a Type II enzyme derived from a strain of Trichoderma.
12. The animal feed additive according to claim 11, in which the Type II
enzyme is derived from a strain of Trichoderma longibrachiatum or a strain of Trichoderma reesei.
enzyme is derived from a strain of Trichoderma longibrachiatum or a strain of Trichoderma reesei.
13. The animal feed additive according to any of claims 3-12, in which at least one xylanolytic enzyme is provided in the form of a monocomponent preparation.
14. The animal feed additive according to claim 9, in which the Type I enzyme derived from a strain of Thermomyces lanuginosus is provided in the form of a monocomponent preparation.
15. The animal feed additive according to either of claims 11-12, in which the Type II enzyme derived from a strain of Trichoderma is provided in the form of a monocomponent preparation.
16. The animal feed additive according to any of claims 3-15, in which all xylanolytic enzymes are provided in the form of monocomponent preparations.
17. The animal feed additive according to any of claims 3-16, which additive further comprises one or more additional feed enhancing enzymes.
18. The animal feed additive according to claim 17, in which the additional feed enhancing enzymes are selected from the group consisting of other xylanases, .alpha.-galactosidases, .beta.-galactosidases, lactases, phytases, .beta.-glucanases, endo-.beta.-1,4-glucanases and endo-.beta.-1,3(4)-glucanases, xylosidases, galactanases, arabinogalactan endo-1,4-.beta.-galactosidases and arabinogalactan endo-1,3-.beta.-galactosidases, endoglucanases, endo-1,2-.beta.-glucanase, endo-1,3-.alpha.-glucanase, and endo-1,3-.beta.-glucanase, pectin degrading enzymes, pectinases, pectinesterases, pectin lyases, polygalacturonases, arabinanases, rhamnogalacturonases, rhamnogalacturonan acetyl esterases, rhamnogalacturonan-.alpha.-rhamnosidase, pectate lyases, and .alpha.-galacturonisidases, mannanases, .beta.-mannosidases, mannan acetyl esterases, xylan acetyl esterases, proteases and lipolytic enzymes lipases and cutinases.
19. A method of preparing an animal feed according to claim 2 wherein the feed is mixed with one or more Type I enzymes and one or more Type II enzymes.
20. A method of preparing an animal feed additive according to claim 3 wherein one or more Type I enzymes and one or more Type II enzymes are mixed with suitable carriers and/or excipients.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK47896 | 1996-04-23 | ||
DK0478/96 | 1996-04-23 | ||
PCT/DK1997/000172 WO1997039638A1 (en) | 1996-04-23 | 1997-04-17 | Animal feed additives |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2251798A1 CA2251798A1 (en) | 1997-10-30 |
CA2251798C true CA2251798C (en) | 2006-06-13 |
Family
ID=36587592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002251798A Expired - Fee Related CA2251798C (en) | 1996-04-23 | 1997-04-17 | Animal feed additives |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2251798C (en) |
-
1997
- 1997-04-17 CA CA002251798A patent/CA2251798C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2251798A1 (en) | 1997-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5720971A (en) | Enzyme additives for ruminant feeds | |
US8043844B2 (en) | Mixture obtained from penicillium funiculosum | |
ES2242970T3 (en) | NEW COMPOSITION OF XYLLASE AND METHOD FOR YOUR PRODUCTION. | |
Beauchemin et al. | Developments in enzyme usage in ruminants. | |
HUT75662A (en) | Use of a thermostable enzyme as a feed additive | |
US5662901A (en) | Enzymatic grain conditioner and methods of using it | |
EP0704167A1 (en) | An enzyme feed additive and animal feed including it | |
AU730501B2 (en) | Animal feed additives | |
Zyla et al. | Comparison of the efficacies of a novel Aspergillus niger mycelium with separate and combined effectiveness of phytase, acid phosphatase, and pectinase in dephosphorylation of wheat-based feeds fed to growing broilers | |
US6162473A (en) | Hemicellulase use in feeds with low caloric content | |
EP0280226A2 (en) | Poultry feed, feeding method, and procedure for improving the digestibility of poultry feed | |
CA2251798C (en) | Animal feed additives | |
EP0906030B1 (en) | Hemicellulase use in feeds with low caloric content | |
AU2014339904B2 (en) | Use of ferulic acid esterase to improve performance in monogastric animals | |
Park et al. | Enzymes and Enzyme Supplementation of Swine Diets | |
RU2819918C1 (en) | PENICILLIUM VERRUCULOSUM FUNGUS STRAIN AS PRODUCER OF COMPLEX OF PHYTASE A AND ENDO-1,4-β-XYLANASE E AND ENZYME PREPARATION BASED ON IT FOR USE AS ADDITIVE IN FEED | |
CN109221674A (en) | Fattening Sheep adequate diet pellet and preparation method based on millet straw and corn stalk | |
GB2303043A (en) | An enzyme supplement in dry pet food | |
CN105087523A (en) | Complex enzyme for animal feed and application of complex enzyme | |
Jurkovich | Use of fibrolytic enzymes produced by the fungus Thermomyces lanuginosus in ruminant nutrition | |
WO2020254296A1 (en) | Feed supplementation composition for increasing milk fat yield | |
CN112956589A (en) | Method for reducing content of crude fiber of whole wheat flour for feed | |
Bloxham | Evaluation of the use of wheat in nursery pig diets | |
WO2001062103A1 (en) | Enzyme preparations for ruminant feeds | |
MXPA00000279A (en) | Enzymes mixture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed | ||
MKLA | Lapsed |
Effective date: 20100419 |